nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—Diphenhydramine—atopic dermatitis	0.44	1	CrCtD
Brompheniramine—Captodiame—Diphenhydramine—atopic dermatitis	0.0346	0.122	CrCrCtD
Brompheniramine—CHRM2—Dimenhydrinate—atopic dermatitis	0.033	0.121	CbGbCtD
Brompheniramine—HRH1—Dimenhydrinate—atopic dermatitis	0.0301	0.111	CbGbCtD
Brompheniramine—Bromodiphenhydramine—Dimenhydrinate—atopic dermatitis	0.0296	0.104	CrCrCtD
Brompheniramine—Dexbrompheniramine—Diphenhydramine—atopic dermatitis	0.025	0.0879	CrCrCtD
Brompheniramine—KCNH2—Loratadine—atopic dermatitis	0.0249	0.0917	CbGbCtD
Brompheniramine—Orphenadrine—Dimenhydrinate—atopic dermatitis	0.0233	0.0818	CrCrCtD
Brompheniramine—Carbinoxamine—Diphenhydramine—atopic dermatitis	0.0213	0.0749	CrCrCtD
Brompheniramine—Diphenhydramine—Dimenhydrinate—atopic dermatitis	0.0207	0.0727	CrCrCtD
Brompheniramine—Chlorphenamine—Diphenhydramine—atopic dermatitis	0.0199	0.0699	CrCrCtD
Brompheniramine—Dimetindene—Diphenhydramine—atopic dermatitis	0.0176	0.0618	CrCrCtD
Brompheniramine—Doxylamine—Diphenhydramine—atopic dermatitis	0.0166	0.0584	CrCrCtD
Brompheniramine—CHRM2—Diphenhydramine—atopic dermatitis	0.0161	0.0592	CbGbCtD
Brompheniramine—CYP2C8—Mometasone—atopic dermatitis	0.016	0.0589	CbGbCtD
Brompheniramine—Tripelennamine—Diphenhydramine—atopic dermatitis	0.015	0.0529	CrCrCtD
Brompheniramine—HRH1—Diphenhydramine—atopic dermatitis	0.0147	0.054	CbGbCtD
Brompheniramine—HRH1—Loratadine—atopic dermatitis	0.0147	0.054	CbGbCtD
Brompheniramine—Bromodiphenhydramine—Diphenhydramine—atopic dermatitis	0.014	0.0494	CrCrCtD
Brompheniramine—Pheniramine—Diphenhydramine—atopic dermatitis	0.0137	0.0484	CrCrCtD
Brompheniramine—CYP2B6—Diphenhydramine—atopic dermatitis	0.0121	0.0446	CbGbCtD
Brompheniramine—Clofedanol—Diphenhydramine—atopic dermatitis	0.0114	0.0401	CrCrCtD
Brompheniramine—Orphenadrine—Diphenhydramine—atopic dermatitis	0.011	0.0388	CrCrCtD
Brompheniramine—Promazine—Diphenhydramine—atopic dermatitis	0.0105	0.0371	CrCrCtD
Brompheniramine—CYP2C8—Loratadine—atopic dermatitis	0.0092	0.0338	CbGbCtD
Brompheniramine—CYP3A4—Pimecrolimus—atopic dermatitis	0.00857	0.0315	CbGbCtD
Brompheniramine—CYP2C19—Loratadine—atopic dermatitis	0.00772	0.0284	CbGbCtD
Brompheniramine—CYP2C19—Diphenhydramine—atopic dermatitis	0.00772	0.0284	CbGbCtD
Brompheniramine—CYP2C9—Loratadine—atopic dermatitis	0.00642	0.0236	CbGbCtD
Brompheniramine—CYP2C9—Diphenhydramine—atopic dermatitis	0.00642	0.0236	CbGbCtD
Brompheniramine—CYP2D6—Loratadine—atopic dermatitis	0.00587	0.0216	CbGbCtD
Brompheniramine—CYP2D6—Diphenhydramine—atopic dermatitis	0.00587	0.0216	CbGbCtD
Brompheniramine—CYP2C8—Hydrocortisone—atopic dermatitis	0.00512	0.0188	CbGbCtD
Brompheniramine—CYP3A4—Tacrolimus—atopic dermatitis	0.0051	0.0187	CbGbCtD
Brompheniramine—CYP2C19—Prednisone—atopic dermatitis	0.00428	0.0157	CbGbCtD
Brompheniramine—CYP2E1—Dexamethasone—atopic dermatitis	0.00426	0.0157	CbGbCtD
Brompheniramine—CYP2B6—Dexamethasone—atopic dermatitis	0.0042	0.0154	CbGbCtD
Brompheniramine—CYP3A4—Loratadine—atopic dermatitis	0.00373	0.0137	CbGbCtD
Brompheniramine—CYP3A4—Methylprednisolone—atopic dermatitis	0.00341	0.0125	CbGbCtD
Brompheniramine—CYP2C8—Dexamethasone—atopic dermatitis	0.00318	0.0117	CbGbCtD
Brompheniramine—CYP2C19—Dexamethasone—atopic dermatitis	0.00267	0.00981	CbGbCtD
Brompheniramine—CYP3A4—Triamcinolone—atopic dermatitis	0.00259	0.0095	CbGbCtD
Brompheniramine—CYP2C9—Dexamethasone—atopic dermatitis	0.00222	0.00816	CbGbCtD
Brompheniramine—CYP3A4—Betamethasone—atopic dermatitis	0.00222	0.00815	CbGbCtD
Brompheniramine—CYP3A4—Prednisolone—atopic dermatitis	0.00219	0.00805	CbGbCtD
Brompheniramine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00208	0.00763	CbGbCtD
Brompheniramine—CYP3A4—Prednisone—atopic dermatitis	0.00207	0.0076	CbGbCtD
Brompheniramine—CYP2D6—Dexamethasone—atopic dermatitis	0.00203	0.00746	CbGbCtD
Brompheniramine—CYP3A4—Dexamethasone—atopic dermatitis	0.00129	0.00474	CbGbCtD
Brompheniramine—CHRM4—Signaling Pathways—STAT6—atopic dermatitis	3.98e-06	0.00104	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCL27—atopic dermatitis	3.96e-06	0.00103	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—CXCL10—atopic dermatitis	3.95e-06	0.00103	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CCR3—atopic dermatitis	3.95e-06	0.00103	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCL27—atopic dermatitis	3.95e-06	0.00103	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CCR3—atopic dermatitis	3.94e-06	0.00103	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCL27—atopic dermatitis	3.94e-06	0.00103	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CCR3—atopic dermatitis	3.93e-06	0.00103	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—CCL5—atopic dermatitis	3.91e-06	0.00102	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCL27—atopic dermatitis	3.9e-06	0.00102	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CCR3—atopic dermatitis	3.89e-06	0.00102	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—TAC1—atopic dermatitis	3.88e-06	0.00101	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—NPS—atopic dermatitis	3.88e-06	0.00101	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—TAC1—atopic dermatitis	3.87e-06	0.00101	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—NPS—atopic dermatitis	3.87e-06	0.00101	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GLB1—atopic dermatitis	3.87e-06	0.00101	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—TAC1—atopic dermatitis	3.86e-06	0.00101	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—NPS—atopic dermatitis	3.86e-06	0.00101	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—TAC1—atopic dermatitis	3.82e-06	0.000996	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—NPS—atopic dermatitis	3.82e-06	0.000996	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—STAT6—atopic dermatitis	3.81e-06	0.000995	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CXCR3—atopic dermatitis	3.81e-06	0.000993	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	3.79e-06	0.00099	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GLB1—atopic dermatitis	3.79e-06	0.000988	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CXCR3—atopic dermatitis	3.78e-06	0.000987	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR ligand binding—CXCL8—atopic dermatitis	3.77e-06	0.000985	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—CCL5—atopic dermatitis	3.75e-06	0.000978	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CXCR3—atopic dermatitis	3.74e-06	0.000977	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ADSL—atopic dermatitis	3.71e-06	0.000967	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ADSL—atopic dermatitis	3.63e-06	0.000947	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR ligand binding—CXCL8—atopic dermatitis	3.61e-06	0.000943	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—IL5—atopic dermatitis	3.61e-06	0.000941	CbGpPWpGaD
Brompheniramine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.6e-06	0.000939	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—IL5—atopic dermatitis	3.6e-06	0.000938	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—IL5—atopic dermatitis	3.58e-06	0.000935	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—CCL5—atopic dermatitis	3.56e-06	0.000928	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCL17—atopic dermatitis	3.55e-06	0.000928	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—IL5—atopic dermatitis	3.55e-06	0.000926	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCL17—atopic dermatitis	3.54e-06	0.000925	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCL17—atopic dermatitis	3.53e-06	0.000922	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—CCR5—atopic dermatitis	3.53e-06	0.00092	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—NPS—atopic dermatitis	3.52e-06	0.00092	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—TAC1—atopic dermatitis	3.52e-06	0.00092	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—TAC1—atopic dermatitis	3.51e-06	0.000917	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—NPS—atopic dermatitis	3.51e-06	0.000917	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—TAC1—atopic dermatitis	3.5e-06	0.000914	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—NPS—atopic dermatitis	3.5e-06	0.000914	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCL17—atopic dermatitis	3.5e-06	0.000913	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—TAC1—atopic dermatitis	3.47e-06	0.000905	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—NPS—atopic dermatitis	3.47e-06	0.000905	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CXCR3—atopic dermatitis	3.46e-06	0.000902	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCR3—atopic dermatitis	3.45e-06	0.000901	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CXCR3—atopic dermatitis	3.45e-06	0.000899	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CXCR3—atopic dermatitis	3.43e-06	0.000896	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—CCL5—atopic dermatitis	3.4e-06	0.000888	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CXCR3—atopic dermatitis	3.4e-06	0.000887	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—CCR5—atopic dermatitis	3.38e-06	0.000881	CbGpPWpGaD
Brompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.35e-06	0.000875	CbGpPWpGaD
Brompheniramine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.34e-06	0.000872	CbGpPWpGaD
Brompheniramine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.33e-06	0.000869	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCR3—atopic dermatitis	3.31e-06	0.000863	CbGpPWpGaD
Brompheniramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.3e-06	0.000861	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL5—atopic dermatitis	3.28e-06	0.000855	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GLB1—atopic dermatitis	3.27e-06	0.000854	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL5—atopic dermatitis	3.27e-06	0.000852	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL5—atopic dermatitis	3.26e-06	0.00085	CbGpPWpGaD
Brompheniramine—CHRM2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	3.23e-06	0.000844	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL5—atopic dermatitis	3.22e-06	0.000841	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—CCR5—atopic dermatitis	3.2e-06	0.000836	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—KIF3A—atopic dermatitis	3.17e-06	0.000827	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—KIF3A—atopic dermatitis	3.16e-06	0.000824	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—KIF3A—atopic dermatitis	3.15e-06	0.000821	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ADSL—atopic dermatitis	3.14e-06	0.000819	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—KIF3A—atopic dermatitis	3.12e-06	0.000814	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TAC1—atopic dermatitis	3.08e-06	0.000803	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NPS—atopic dermatitis	3.08e-06	0.000803	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CXCL10—atopic dermatitis	3.08e-06	0.000803	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—CCR5—atopic dermatitis	3.07e-06	0.0008	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	3.07e-06	0.0008	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CXCL10—atopic dermatitis	3.06e-06	0.000798	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CXCL10—atopic dermatitis	3.03e-06	0.00079	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CXCR3—atopic dermatitis	3.02e-06	0.000788	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TAC1—atopic dermatitis	2.95e-06	0.000769	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NPS—atopic dermatitis	2.95e-06	0.000769	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GLB1—atopic dermatitis	2.92e-06	0.000762	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCR3—atopic dermatitis	2.89e-06	0.000754	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCL11—atopic dermatitis	2.87e-06	0.000748	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CMA1—atopic dermatitis	2.87e-06	0.000748	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL5—atopic dermatitis	2.86e-06	0.000747	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCL11—atopic dermatitis	2.86e-06	0.000745	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CMA1—atopic dermatitis	2.86e-06	0.000745	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCL11—atopic dermatitis	2.85e-06	0.000743	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CMA1—atopic dermatitis	2.85e-06	0.000743	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CMA1—atopic dermatitis	2.82e-06	0.000736	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCL11—atopic dermatitis	2.82e-06	0.000736	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ADSL—atopic dermatitis	2.8e-06	0.000731	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CXCL10—atopic dermatitis	2.79e-06	0.000729	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CXCL10—atopic dermatitis	2.78e-06	0.000727	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CXCL10—atopic dermatitis	2.78e-06	0.000724	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CXCL10—atopic dermatitis	2.75e-06	0.000717	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL5—atopic dermatitis	2.74e-06	0.000715	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—STAT6—atopic dermatitis	2.69e-06	0.000703	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GLB1—atopic dermatitis	2.69e-06	0.000701	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—STAT6—atopic dermatitis	2.69e-06	0.000701	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—STAT6—atopic dermatitis	2.68e-06	0.000699	CbGpPWpGaD
Brompheniramine—CHRM1—Circadian rythm related genes—IL6—atopic dermatitis	2.67e-06	0.000698	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GLB1—atopic dermatitis	2.66e-06	0.000695	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—STAT6—atopic dermatitis	2.65e-06	0.000692	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CCL5—atopic dermatitis	2.65e-06	0.000691	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CCL5—atopic dermatitis	2.64e-06	0.000689	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CCL5—atopic dermatitis	2.63e-06	0.000687	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CCL5—atopic dermatitis	2.61e-06	0.00068	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ADSL—atopic dermatitis	2.58e-06	0.000672	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ADSL—atopic dermatitis	2.55e-06	0.000666	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—CXCL8—atopic dermatitis	2.55e-06	0.000666	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—CXCL8—atopic dermatitis	2.54e-06	0.000664	CbGpPWpGaD
Brompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.54e-06	0.000663	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—CXCL8—atopic dermatitis	2.54e-06	0.000662	CbGpPWpGaD
Brompheniramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.53e-06	0.000661	CbGpPWpGaD
Brompheniramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.53e-06	0.000659	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—CXCL8—atopic dermatitis	2.51e-06	0.000655	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CXCL10—atopic dermatitis	2.44e-06	0.000637	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CCL5—atopic dermatitis	2.4e-06	0.000628	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CCL5—atopic dermatitis	2.4e-06	0.000626	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CCL5—atopic dermatitis	2.39e-06	0.000624	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CCR5—atopic dermatitis	2.39e-06	0.000623	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.38e-06	0.000622	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CCR5—atopic dermatitis	2.38e-06	0.000621	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CCR5—atopic dermatitis	2.37e-06	0.000619	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CCL5—atopic dermatitis	2.37e-06	0.000617	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CCR5—atopic dermatitis	2.35e-06	0.000613	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCL10—atopic dermatitis	2.34e-06	0.00061	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCR3—atopic dermatitis	2.34e-06	0.00061	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCR3—atopic dermatitis	2.33e-06	0.000608	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCR3—atopic dermatitis	2.32e-06	0.000606	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCR3—atopic dermatitis	2.3e-06	0.0006	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CCR5—atopic dermatitis	2.17e-06	0.000565	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	2.16e-06	0.000564	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CCR5—atopic dermatitis	2.15e-06	0.000562	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—CXCL8—atopic dermatitis	2.13e-06	0.000556	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	2.13e-06	0.000556	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.13e-06	0.000555	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCL5—atopic dermatitis	2.1e-06	0.000548	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TAC1—atopic dermatitis	2.08e-06	0.000543	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NPS—atopic dermatitis	2.08e-06	0.000543	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NPS—atopic dermatitis	2.08e-06	0.000542	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	2.08e-06	0.000542	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NPS—atopic dermatitis	2.07e-06	0.00054	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TAC1—atopic dermatitis	2.07e-06	0.00054	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	2.05e-06	0.000535	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NPS—atopic dermatitis	2.05e-06	0.000535	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—CXCL8—atopic dermatitis	2.04e-06	0.000533	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCR3—atopic dermatitis	2.04e-06	0.000533	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—IL2—atopic dermatitis	2.04e-06	0.000532	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	2.04e-06	0.000531	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCR3—atopic dermatitis	2.03e-06	0.000529	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCL5—atopic dermatitis	2.01e-06	0.000525	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	2.01e-06	0.000524	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—IL2—atopic dermatitis	1.95e-06	0.000509	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NGF—atopic dermatitis	1.94e-06	0.000508	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.94e-06	0.000506	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—CXCL8—atopic dermatitis	1.94e-06	0.000505	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL5—atopic dermatitis	1.94e-06	0.000505	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL5—atopic dermatitis	1.93e-06	0.000503	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL5—atopic dermatitis	1.92e-06	0.000502	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL5—atopic dermatitis	1.9e-06	0.000497	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCR5—atopic dermatitis	1.89e-06	0.000494	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NGF—atopic dermatitis	1.86e-06	0.000486	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—CXCL8—atopic dermatitis	1.85e-06	0.000484	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL2—atopic dermatitis	1.85e-06	0.000483	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCR5—atopic dermatitis	1.81e-06	0.000473	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL2—atopic dermatitis	1.77e-06	0.000462	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.76e-06	0.000458	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.68e-06	0.000439	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	1.65e-06	0.000431	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	1.65e-06	0.000429	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	1.64e-06	0.000428	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	1.62e-06	0.000424	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	1.6e-06	0.000419	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	1.54e-06	0.000401	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PPARA—atopic dermatitis	1.46e-06	0.00038	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.44e-06	0.000376	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.44e-06	0.000375	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	1.43e-06	0.000374	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCL5—atopic dermatitis	1.42e-06	0.000371	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.42e-06	0.00037	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	1.42e-06	0.00037	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	1.41e-06	0.000368	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	1.4e-06	0.000365	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	1.38e-06	0.00036	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	1.37e-06	0.000359	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	1.37e-06	0.000357	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	1.36e-06	0.000354	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NGF—atopic dermatitis	1.32e-06	0.000343	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NGF—atopic dermatitis	1.31e-06	0.000342	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	1.31e-06	0.000342	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NGF—atopic dermatitis	1.31e-06	0.000341	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	1.31e-06	0.000341	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	1.3e-06	0.00034	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NGF—atopic dermatitis	1.29e-06	0.000338	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	1.29e-06	0.000336	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCR5—atopic dermatitis	1.28e-06	0.000334	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	1.28e-06	0.000333	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	1.27e-06	0.000332	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	1.26e-06	0.000329	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PPARA—atopic dermatitis	1.25e-06	0.000327	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL2—atopic dermatitis	1.25e-06	0.000327	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	1.25e-06	0.000326	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	1.24e-06	0.000325	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	1.23e-06	0.000321	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PPARA—atopic dermatitis	1.23e-06	0.000321	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	1.14e-06	0.000298	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	1.1e-06	0.000286	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL2—atopic dermatitis	1.09e-06	0.000285	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	1.09e-06	0.000284	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	1.09e-06	0.000283	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	1.08e-06	0.000282	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	1.08e-06	0.000281	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	1.07e-06	0.000279	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PPARA—atopic dermatitis	1.06e-06	0.000277	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL2—atopic dermatitis	1.05e-06	0.000273	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	1.04e-06	0.000272	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	1.01e-06	0.000263	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	9.64e-07	0.000251	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PPARA—atopic dermatitis	9.48e-07	0.000247	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PPARA—atopic dermatitis	8.72e-07	0.000227	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PPARA—atopic dermatitis	8.64e-07	0.000226	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	7.74e-07	0.000202	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	7.71e-07	0.000201	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	7.69e-07	0.000201	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	7.61e-07	0.000199	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2—atopic dermatitis	7.39e-07	0.000193	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2—atopic dermatitis	7.37e-07	0.000192	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—atopic dermatitis	7.36e-07	0.000192	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2—atopic dermatitis	7.35e-07	0.000192	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	7.33e-07	0.000191	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	7.31e-07	0.000191	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2—atopic dermatitis	7.28e-07	0.00019	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	7.24e-07	0.000189	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	6.81e-07	0.000178	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	6.78e-07	0.000177	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	6.76e-07	0.000176	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	6.7e-07	0.000175	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—atopic dermatitis	6.43e-07	0.000168	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—atopic dermatitis	6.15e-07	0.000161	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PPARA—atopic dermatitis	5.7e-07	0.000149	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—atopic dermatitis	4.35e-07	0.000113	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—atopic dermatitis	4.33e-07	0.000113	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—atopic dermatitis	4.32e-07	0.000113	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—atopic dermatitis	4.28e-07	0.000112	CbGpPWpGaD
